Unbiased Analysis of Today's Healthcare Issues
That is the title of my most recent paper published in Clinical Lung Cancer with co-authors Mark Danese, Melissa Laurie, Beata Korytowsky, Shane Jordan, Debbie Ryan and Sukhmani K. Padda. The study abstract is below. ObjectiveThis study examined brain metastases among patients with metastatic non-small cell lung cancer (mNSCLC), characterizing prevalence, use of brain imaging,…
That is the topic from a recent study by Hayes et al. (2024): Payments for some diagnostic scans undertaken in outpatient settings were unbundled from Diagnosis Related Group based payments in England in April 2013 to address under-provision. Unbundled scans attracted additional payments of between £45 and £748 directly following the reform. We examined the…
Reference-based pricing seems like an attractive option. Basically, health insurers pay some amount (e.g., the lowest price, median price, average of lowest X prices) for a given service. If patients want a higher priced option, they must pay the difference. The approach assures patients have access to care but makes patients responsible if they don’t…
“Our imaging and diagnostic tests are so good, we can see things we couldn’t see before. But our ability to understand what we’re seeing and to know if we should intervene hasn’t kept up.” Michael Lauer, National Heart Lung, and Blood Institute via Newsweek.
For many years, the Dartmouth Atlas has chronicled how variation in medical resource use across the country. Despite glaring differences in the cost and volume of care across the nation, regions with higher health care costs do not necessarily have better health outcomes. However, medical treatment is a two step process. First, the physician must…